Neurologic Sequela of COVID-19.Guillain Barré Syndrome Following Johnson and Johnson COVID-19 Vaccination;A Case report
Neurology
; 98(18 SUPPL), 2022.
Article
in English
| EMBASE | ID: covidwho-1925155
ABSTRACT
Objective:
Outbreak of novel coronavirus-19 (COVID-19) began in December 2019 in Wuhan, China and became global pandemic by March 2020. Federal Drug administration (FDA) has approved three vaccines for prevention of COVID-19 infection. Multiple neurological complications have been reported following vaccine administration. In July 2021 FDA issued warning about increased risk of Guillain Barre Syndrome (GBS) following Johnson and Johnson (J&J) vaccine and since then cases have been reported during clinical trials. Here we report a real life case of GBS after receiving single dose of J&J vaccine.Background:
A 53 year old female presented to emergency department with progressive bilateral symmetric proximal more than distal upper and lower extremity weakness, with bilateral ascending paresthesia's, 14 days after receiving the J&J COVID-19 vaccination. Exam consistent with motor strength 4/5 in hip flexors/extensors bilaterally, 4/5 knee extensors/flexors, 4/5 plantar flexion, 4/5 dorsiflexion bilaterally, 4/5 shoulder abductors/adductors, 4/5 elbow extensor/flexors, 2+ patellar reflex, 1+ Achilles tendon reflex bilaterally and decrease sensation to light touch and pinprick in lower extremities till mid-thigh bilaterally. MRI of the Lumbar Spine with and without contrast revealed subtle enhancement of the cauda equina nerve roots suggestive of Acute Inflammatory Demyelinating Polyradiculoneuropathy. CSF analysis consistent with mildly elevated protein 48, nucleated cell count of 0, glucose of 52. Negative GM1 and Gq1b antibodies. Due to the high suspicion for Guillain-Barre syndrome the patient was started on IVIG. After 5 days of treatment the patient had significant improvement and was discharged to rehab facility. Design/Methods:
NAResults:
NAConclusions:
As we continue mass vaccinations for COVID-19 prevention, clinicians should be able to recognize potential complications and side effects associated with COVID-19 vaccination and must educate and reassure their patients regarding the safety and rationale of COVID-19 vaccination because the benefits of vaccination outweigh the risks of COVID-19 infection and associated morbidity and mortality.
glucose; human immunoglobulin; vaccine; achilles reflex; acute inflammatory demyelinating polyneuropathy; adult; case report; cauda equina; cell count; cerebrospinal fluid; clinical article; complication; conference abstract; coronavirus disease 2019; drug safety; drug therapy; elbow; emergency ward; female; Guillain Barre syndrome; hip; human; knee; lower limb; lumbar spine; male; mass immunization; middle aged; morbidity; mortality; nerve root; neurological complication; nuclear magnetic resonance imaging; paresthesia; shoulder; side effect; thigh; touch; vaccination; weakness
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Neurology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS